[go: up one dir, main page]

NO863000L - Fusjonsproteiner og fremgangsmaate til fremstilling derav. - Google Patents

Fusjonsproteiner og fremgangsmaate til fremstilling derav.

Info

Publication number
NO863000L
NO863000L NO86863000A NO863000A NO863000L NO 863000 L NO863000 L NO 863000L NO 86863000 A NO86863000 A NO 86863000A NO 863000 A NO863000 A NO 863000A NO 863000 L NO863000 L NO 863000L
Authority
NO
Norway
Prior art keywords
sequence
amino acids
genetically codable
genetically
fusion protein
Prior art date
Application number
NO86863000A
Other languages
English (en)
Other versions
NO175640B (no
NO175640C (no
NO863000D0 (no
Inventor
Paul Habermann
Siegfried Stengelin
Friedrich Wengenmayer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO863000D0 publication Critical patent/NO863000D0/no
Publication of NO863000L publication Critical patent/NO863000L/no
Publication of NO175640B publication Critical patent/NO175640B/no
Publication of NO175640C publication Critical patent/NO175640C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO863000A 1985-07-27 1986-07-25 Fusjonsproteiner og DNA som koder for disse NO175640C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853526995 DE3526995A1 (de) 1985-07-27 1985-07-27 Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung

Publications (4)

Publication Number Publication Date
NO863000D0 NO863000D0 (no) 1986-07-25
NO863000L true NO863000L (no) 1987-01-28
NO175640B NO175640B (no) 1994-08-01
NO175640C NO175640C (no) 1994-11-09

Family

ID=6276985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863000A NO175640C (no) 1985-07-27 1986-07-25 Fusjonsproteiner og DNA som koder for disse

Country Status (18)

Country Link
EP (1) EP0211299B1 (no)
JP (1) JPH07113040B2 (no)
KR (1) KR950000299B1 (no)
AT (1) ATE50596T1 (no)
AU (1) AU595221B2 (no)
CA (1) CA1336329C (no)
DE (2) DE3526995A1 (no)
DK (1) DK172618B1 (no)
ES (1) ES2000278A6 (no)
FI (1) FI86887C (no)
GR (1) GR861957B (no)
HU (1) HU197356B (no)
IE (1) IE59127B1 (no)
IL (1) IL79522A (no)
NO (1) NO175640C (no)
NZ (1) NZ216967A (no)
PT (1) PT83065B (no)
ZA (1) ZA865556B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
ATE80913T1 (de) * 1986-03-12 1992-10-15 Int Minerals & Chem Corp Hybride expressionsvektoren, deren herstellung und verwendungen.
EP0371041A1 (en) * 1987-06-24 1990-06-06 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DE3942580A1 (de) * 1989-12-22 1991-06-27 Basf Ag Verfahren zur herstellung von hirudin
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PL2201120T3 (pl) 2007-09-21 2014-05-30 Cadila Healthcare Ltd Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
CN103736082A (zh) 2008-10-17 2014-04-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
AU2010317995B2 (en) 2009-11-13 2014-04-17 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
CN102711804B (zh) 2009-11-13 2015-09-16 赛诺菲-安万特德国有限公司 包含glp-1激动剂和甲硫氨酸的药物组合物
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
ES2550357T3 (es) 2011-08-29 2015-11-06 Sanofi-Aventis Deutschland Gmbh Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
KR102578030B1 (ko) 2014-12-12 2023-09-14 사노피-아벤티스 도이칠란트 게엠베하 인슐린 글라진/릭시세나티드 고정비 제형
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
KR20200080747A (ko) 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
KR20200080748A (ko) 2018-12-27 2020-07-07 주식회사 폴루스 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68404B (no) * 1979-06-01 1981-12-29 Univ California
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
AU596585B2 (en) * 1985-03-18 1990-05-10 Genelabs Incorporated Hybrid genes (eg. ig's & mhc proteins) via lambda library andplasmid casette vector
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
EP0220234B1 (en) * 1985-04-08 1994-08-03 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV

Also Published As

Publication number Publication date
FI86887C (fi) 1992-10-26
DK355486A (da) 1987-01-28
PT83065B (pt) 1989-02-28
IE861977L (en) 1987-01-27
FI863041A0 (fi) 1986-07-24
FI86887B (fi) 1992-07-15
GR861957B (en) 1986-11-25
AU595221B2 (en) 1990-03-29
ES2000278A6 (es) 1988-02-01
IE59127B1 (en) 1994-01-12
FI863041L (fi) 1987-01-28
CA1336329C (en) 1995-07-18
DK172618B1 (da) 1999-03-01
KR950000299B1 (ko) 1995-01-13
JPS6229600A (ja) 1987-02-07
IL79522A (en) 1991-08-16
DK355486D0 (da) 1986-07-25
NZ216967A (en) 1988-08-30
NO175640B (no) 1994-08-01
PT83065A (de) 1986-08-01
ATE50596T1 (de) 1990-03-15
DE3669175D1 (de) 1990-04-05
KR870001312A (ko) 1987-03-13
IL79522A0 (en) 1986-10-31
AU6056586A (en) 1987-01-29
ZA865556B (en) 1987-03-25
HU197356B (en) 1989-03-28
EP0211299A3 (en) 1988-06-01
NO175640C (no) 1994-11-09
NO863000D0 (no) 1986-07-25
HUT43629A (en) 1987-11-30
EP0211299B1 (de) 1990-02-28
DE3526995A1 (de) 1987-02-05
JPH07113040B2 (ja) 1995-12-06
EP0211299A2 (de) 1987-02-25

Similar Documents

Publication Publication Date Title
NO863000L (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
FI880017A0 (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
ATE91722T1 (de) Pferde-gamma-interferon.
AU2795989A (en) Production of gonorrheal pi proteins and vaccines
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
EP0330700A4 (en) Human prourokinase-like polypeptide.
ATE46188T1 (de) Positionsspezifische proteolyse mittels renin.
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
FI934079L (fi) Menetelmä fuusioproteiinin valmistamiseksi
JPS6438099A (en) Fused protein or dihydrofolate reductase and bradykinin